16th Sep 2024 2:31 pm |
RNS |
PDS: Updated Results, VERSATILE-002 Phase 2 Trial |
13th Aug 2024 3:57 pm |
RNS |
PDS Biotech: Business Update and Q2 2024 Results |
2nd Aug 2024 12:21 pm |
RNS |
Replacement RNS: PDS Biotech Aligns with FDA |
2nd Aug 2024 7:00 am |
RNS |
PDS Biotech Aligns with FDA on Phase 3 Trial |
30th Jul 2024 7:00 am |
RNS |
Q-Bot Fundraising |
10th Jul 2024 10:48 am |
RNS |
Result of AGM |
18th Jun 2024 7:00 am |
RNS |
Notice of AGM |
14th Jun 2024 2:10 pm |
RNS |
TR-1 |
14th Jun 2024 7:00 am |
RNS |
Director/PDMR Shareholding |
13th Jun 2024 7:00 am |
RNS |
Preliminary Results for the year ended 31 Dec 2023 |
31st May 2024 7:01 am |
RNS |
Notice of Results and Investor Presentation |
31st May 2024 7:00 am |
RNS |
DeepTech Recycling: Fundraising, Business Update |
28th May 2024 7:00 am |
RNS |
Investment in Wanda, related party transactions |
15th May 2024 2:32 pm |
RNS |
PDS Biotech: Business Update and Q1 2024 Results |
13th May 2024 7:00 am |
RNS |
Martlet Capital: mandate and acquisition |
10th May 2024 9:12 am |
RNS |
PDS Biotech: Clinical trial meets study endpoints |
15th Apr 2024 7:00 am |
RNS |
ProAxsis secures c.£1.8mn investment |
27th Mar 2024 1:34 pm |
RNS |
PDS Strategy Update and 2023 Financial Results |
13th Mar 2024 7:00 am |
RNS |
Business Update |
5th Feb 2024 7:00 am |
RNS |
Exercise of Options and Issue of Shares |
23rd Jan 2024 7:00 am |
RNS |
Glycotest secures $1 million investment |
1st Dec 2023 7:00 am |
RNS |
DeepTech Recycling secures £1 million investment |
14th Nov 2023 4:39 pm |
RNS |
PDS BioTechnology: Third Quarter Results |
13th Nov 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
9th Nov 2023 5:28 pm |
RNS |
PDS Biotech Announces Updated Survival Data |
6th Nov 2023 7:00 am |
RNS |
Ventive secures c.£900,000 investment |
2nd Nov 2023 7:00 am |
RNS |
Change of Adviser |
23rd Oct 2023 6:22 pm |
RNS |
PDS Preliminary Biomarker Study Results |
13th Oct 2023 7:00 am |
RNS |
Exercise of Options |
3rd Oct 2023 4:12 pm |
RNS |
Director/PDMR Shareholding |
3rd Oct 2023 3:21 pm |
RNS |
PDS: Interim 24-month survival rate of 74% update |
3rd Oct 2023 7:00 am |
RNS |
PDS Biotech: new data on PDS0101 |
28th Sep 2023 7:00 am |
RNS |
Interim Results |
13th Sep 2023 7:00 am |
RNS |
Q-Bot: £3.5 million investment to drive expansion |
14th Aug 2023 5:55 pm |
RNS |
PDS Biotech: 2nd Quarter Results, Business Update |
14th Aug 2023 5:51 pm |
RNS |
PDS Biotech: Submission of Phase 3 Protocol to FDA |
3rd Jul 2023 7:00 am |
RNS |
Grant of Options, Issue of Shares, Director/PDMR |
30th Jun 2023 7:00 am |
RNS |
DName-iT Holdings Limited Fundraising |
29th Jun 2023 11:04 am |
RNS |
Result of AGM & Board Changes |
22nd Jun 2023 7:00 am |
RNS |
Vortex Fundraising |